Rick Svetkoff, the founder of Starfighters Space, has stepped down as chief executive, paving the way for Vice President of Development Tim Franta to take the helm. The leadership transition, which includes the departure of company secretary Brenda Svetkoff, triggered a 16% drop in the company's share price.
OpenAI is partnering with Accenture, McKinsey & Co., Boston Consulting Group, and Capgemini to drive corporate adoption of its new "Frontier" agentic AI platform. The collaboration aims to bridge the gap between high-level model intelligence and practical, large-scale implementation within global enterprises.
Stanley Martin Homes has reached a definitive agreement to acquire United Homes in an all-cash transaction with an enterprise value of $221 million. The deal, priced at $1.18 per share, is expected to close in the second quarter and signals a consolidation of the Southeast’s entry-level housing market amid persistent affordability challenges.
Abits Group shares tumbled Tuesday after the cryptocurrency firm announced a $2.1 million registered direct offering priced significantly below its market value. The deal, which includes shares and pre-funded warrants, sent the stock down 25% to $2.79 as investors reacted to the dilutive capital raise.
Akamai Technologies has teamed up with Nvidia to launch a cybersecurity solution tailored for critical infrastructure, aiming to protect vulnerable power grids and factories without disrupting legacy hardware. The partnership integrates Akamai’s software with Nvidia’s BlueField Data Processing Units (DPUs) to secure industrial control systems that are often too fragile for traditional security agents.
Biopharmaceutical giant AbbVie is investing $380 million to construct two advanced manufacturing facilities at its North Chicago headquarters, targeting the high-growth neuroscience and obesity markets. The project, scheduled to begin this spring, represents a key pillar of the company's recent multibillion-dollar commitment to U.S.-based production and research.
Fortress Biotech shares jumped Monday after the company announced an agreement to sell a Rare Pediatric Disease Priority Review Voucher for $205 million in gross proceeds. The deal, executed through its subsidiary Cyprium Therapeutics, provides a significant capital injection as the firm targets a shift to profitability this year.
The U.S. Food and Drug Administration has authorized a label expansion for Eli Lilly’s weight-loss blockbuster Zepbound, introducing a multi-dose pen that provides a full month of treatment in a single device. This update transitions the medication from its previous single-dose vial format, offering a more streamlined delivery method as the pharmaceutical giant scales to meet unprecedented global demand.
Stanley Martin Homes has reached an agreement to acquire United Homes in a transaction valued at $221 million, consolidating two major players in the Southeast’s entry-level housing market. The all-cash deal, priced at $1.18 per share, is expected to close in the second quarter of this year.
Verisk Analytics has entered into accelerated share-repurchase agreements to buy back $1.5 billion of its common stock, tapping HSBC Bank and Wells Fargo to execute the transaction. The move follows a significant increase in the company's buyback authorization and underscores a period of aggressive capital return for the Jersey City-based data firm.
ARCTEC Alaska, a joint venture involving the Canadian infrastructure giant Atco, has secured a $596 million contract from the U.S. Air Force to maintain the Alaska Radar System. The 10-year agreement, scheduled to begin in September, tasks the group with overseeing critical early-warning infrastructure essential to North American aerospace defense.
Shutterstock and Getty Images stock prices surged in premarket trading Monday after the U.S. Department of Justice cleared their proposed $3.7 billion merger. The federal agency concluded its review without imposing conditions, removing a primary regulatory barrier for the creation of a visual content powerhouse.
B2Gold Corp. announced a major leadership transition on Monday, naming longtime CFO Mike Cinnamond as the successor to founding Chief Executive Clive Johnson. Johnson, who has led the Canadian gold producer since its inception in 2007, will retire following the company’s annual general meeting on June 4, marking the end of an era that saw the firm grow into a global producer yielding approximately 1 million ounces of gold annually.
Gossamer Bio shares plummeted 82% in premarket trading after the company announced that its Phase 3 study of seralutinib for pulmonary arterial hypertension failed to meet its primary statistical threshold, despite showing some clinical benefits.
Rick Svetkoff, the founder of Starfighters Space, has resigned as chief executive of the supersonic launch provider, with Vice President of Development Tim Franta stepping in to lead the company. The leadership transition marks a significant shift for the Florida-based firm that has operated its unique fleet of modified aircraft since 1996.
Vanda Pharmaceuticals shares jumped 39% in premarket trading Monday after the FDA approved Bysanti for the treatment of schizophrenia and bipolar I disorder in adults. The regulatory milestone, which includes patent protection through 2044, sets the stage for a commercial launch scheduled for later this year.
HSBC Holdings is expected to report a significant jump in fourth-quarter net profit on Wednesday, fueled by aggressive restructuring efforts and a robust performance in its Asian wealth management division. Analysts surveyed by Visible Alpha anticipate net income will climb to $3.98 billion, a sharp recovery from the $197 million recorded during the same period last year.
Emera reported a sharp decline in fourth-quarter profit on Monday as unseasonably mild weather and softening energy demand pressured its utility operations across North America. Despite missing analyst expectations for the quarter, the Halifax-based company extended its long-term earnings growth targets through the end of the decade.
Foghorn Therapeutics has appointed Ryan Maynard, the former financial chief of Cara Therapeutics, as its new Chief Financial Officer. Maynard brings more than 25 years of executive experience across the biopharmaceutical and healthcare technology sectors to the clinical-stage firm as it scales its operations.
MoonLake Immunotherapeutics shares climbed Monday after the company reported successful Phase 2 trial results for sonelokimab, its experimental treatment for axial spondyloarthritis. The study met its primary endpoints, demonstrating significant clinical benefits for patients suffering from the chronic inflammatory condition and triggering a 6.5% jump in premarket trading.
Stepan, the specialty chemical manufacturer, is shuttering its Fieldsboro, New Jersey facility and scaling back operations at two other sites as part of a sweeping restructuring plan. Dubbed "Project Catalyst," the initiative aims to generate $100 million in pre-tax savings over the next two years to combat cooling demand for commodity surfactants.
Stanley Martin Homes has reached an agreement to acquire United Homes for an enterprise value of $221 million, a strategic move aimed at consolidating its presence in the Southeast’s entry-level housing market. The transaction, expected to close in the second quarter, offers United Homes shareholders $1.18 in cash per share.
Dominion Energy reported a sharp rise in fourth-quarter earnings, posting a profit of $567 million as operating revenue climbed to $4.09 billion. The utility provider's results significantly outpaced the prior year’s performance, setting a foundation for long-term growth targets that extend through the end of the decade.
Mexico’s economic activity accelerated in the final months of 2025, outperforming initial estimates as industrial and service sectors drove the fastest quarterly expansion in over a year.
Australian mining giants are escalating a high-stakes lobbying campaign to protect the A$10.8 billion Fuel Tax Credit Scheme as political pressure builds to redirect the funds toward green energy. With a critical policy conference looming in June 2026, the governing Labor Party faces increasing demands to cap rebates for the industry's largest emitters to accelerate national decarbonization efforts.
Novo Nordisk shares plummeted 16% on Monday after its experimental obesity treatment, CagriSema, failed to outperform Eli Lilly’s rival drug Zepbound in a critical head-to-head clinical trial. The Danish pharmaceutical giant reported that CagriSema missed its primary goal of demonstrating noninferior weight loss, dealing a significant blow to the company's efforts to reclaim dominance in the global weight-loss market.
Samsung Electro-Mechanics shares extended a three-day rally on Monday, jumping 13% to close at 426,500 won as analysts signaled a massive upside for the company’s multilayer ceramic capacitors (MLCCs) fueled by the global artificial intelligence boom.
Clean Max Enviro Energy Solutions, a renewable energy firm backed by Brookfield Asset Management, has opened orders for its $341.7 million initial public offering in India. The company, which provides power to tech giants like Amazon and Google, plans to list on both major Indian exchanges on March 2, capitalizing on a surge of equity market activity in the region.
Goldman Sachs has upwardly revised its year-end oil price forecasts, citing lower-than-anticipated inventory builds across developed economies. The bank now projects Brent crude will reach $60 a barrel in the fourth quarter, up from its previous estimate of $54, as supply disruptions and logistical shifts in sanctioned crude tighten the immediate market outlook.
U.S. stock futures and European equities edged lower in early trading as a decline in energy commodities and cautious sentiment ahead of the New York open pressured major indices.
